IGM Biosciences, Inc.
IGMSNASDAQHealthcare
$1.27
+$0.00(+0.00%)
Market Cap$77498317
P/E Ratio—
52W High$22.5
52W Low$0.92
IGM Biosciences, Inc.（IGMS）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · IGMS · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.68M | $2.13M | $1.07M | $0.00M | $0.00M |
| Cost of Revenue | $9.11M | $8.28M | $10.60M | $7.72M | $3.58M |
| Gross Profit | ($6.43M) | ($6.15M) | ($9.53M) | ($7.72M) | ($3.58M) |
| Gross Margin %(computed) | -240.13% | -288.59% | -891.77% | — | — |
| Operating Expenses | |||||
| R&D Expenses | $160.85M | $215.52M | $179.29M | $127.03M | $65.03M |
| G&A Expenses | $50.41M | $50.07M | $49.74M | $38.30M | $18.25M |
| Total Operating Expenses | $211.26M | $265.59M | $229.03M | $165.32M | $83.28M |
| Operating Income | ($208.58M) | ($263.46M) | ($227.96M) | ($165.32M) | ($83.28M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $12.79M | $17.74M | $7.04M | $0.16M | $1.93M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($195.79M) | ($245.74M) | ($221.10M) | ($165.16M) | ($81.36M) |
| Income Tax Expense | $0.00M | $0.68M | $0.00M | $0.00M | $0.00M |
| Net Income | ($195.79M) | ($246.42M) | ($214.25M) | ($160.68M) | ($80.33M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.24 | $-4.71 | $-5.16 | $-4.80 | $-2.61 |
| Wtd Avg Shares | 60.51M | 52.31M | 41.54M | 33.48M | 30.75M |
| EBITDA | ($199.47M) | ($255.18M) | ($221.88M) | ($157.44M) | ($77.78M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解IGM Biosciences, Inc.
关于IGM Biosciences, Inc.（IGMS）损益表
IGM Biosciences, Inc.（IGMS）损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年，IGMS实现营收$0.00B，毛利润($0.01B)（毛利率-240.13%），净利润($0.20B)（净利率-7308.51%）。
常见问题
IGMS · 4 问IGM Biosciences, Inc.（IGMS）2024财年营收为$0.00B，同比up25.8%。
IGMS revenueIGMS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09